Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03379792 · ClinicalTrials.gov registry record
The Influence of Glycemic Control and Obesity on Energy Balance and Metabolic Flexibility in Type 1 Diabetes
A clinical trial, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- 32
- Enrollment target
NCT03379792: Completed study, sponsored by AdventHealth Translational Research Institute.
NCT03379792 is a clinical trial that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03379792 has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the metabolic phenotype of a range of body weights in individuals with and without type 1 diabetes.
Primary Outcome
Measured via whole room calorimetry; based on oxygen consumption and carbon dioxide production measured using gas analyzers, as well as 14-hour urinary nitrogen excretion; calculated using established equations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2020-07-20 |
What the finished NCT03379792 record still lists
NCT03379792 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03379792 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03379792 about?
NCT03379792 is a clinical study titled "The Influence of Glycemic Control and Obesity on Energy Balance and Metabolic Flexibility in Type 1 Diabetes". The purpose of this study is to measure the metabolic phenotype of a range of body weights in individuals with and without type 1 diabetes.
What is the current status of trial NCT03379792?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2018-03-08. Estimated completion is 2020-07-20.
Who is sponsoring clinical trial NCT03379792?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI